News

Filter

Onconova drops Ph III trial of rigosertib in pancreatic cancer

20-12-2013

US biopharma company Onconova Therapeutics says it has discontinued the Phase III ONTRAC study of intravenous…

OncologyOnconova TherapeuticsPharmaceuticalResearchrigosertib

Onconova could file NDA for cancer drug rigosertib next year

Onconova could file NDA for cancer drug rigosertib next year

15-11-2013

Analysts at Edison Equity Research have indicated that US biopharma company Onconova Therapeutics (Nasdaq:…

FinancialOncologyOnconova TherapeuticsPharmaceuticalResearchrigosertibUSA

Five new drugs for myelodysplastic syndromes set to launch by 2018

10-02-2013

Through 2018, five new drugs will launch for the treatment of myelodysplastic syndromes (MDS), three…

BaxterCyclacelEstybonEuropeGlaxoSmithKlineMarkets & MarketingMerck & CoNorth AmericaOncologyOnconova TherapeuticsPharmaceuticalResearchRevoladesapacitabineZolinza

GVK Biosciences and Onconova in cancer drug development deal

09-01-2013

GVK Biosciences, a Hyderabad, India-based contract research and development organization, and privately-held…

Ex-RADGVK BiosciencesON-013105OncologyOnconova TherapeuticsPharmaceuticalResearchrigosertib

COMPANY SPOTLIGHT

Menarini

Back to top